Integrated analysis identified prognostic microRNAs in breast cancer

被引：0
作者：
Cong Shang
Qingyan Chen
Fuqiang Zu
Weidong Ren
机构：
[1] Shengjing Hospital of China Medical University,Department of Ultrasound
[2] Shengjing Hospital of China Medical University,undefined
来源：
BMC Cancer | / 22卷
关键词：
Breast cancer; Risk model; Nomogram; miR-127; Tumor progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 265 条
  • [1] Siegel RL(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
  • [2] Miller KD(2014)Breast cancer in China Lancet Oncol 15 e279-289
  • [3] Fuchs HE(2019)The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer BMC Cancer 19 1091-874
  • [4] Jemal A(2011)Non-coding RNAs in human disease Nat Rev Genet 12 861-437
  • [5] Fan L(2014)The rise of regulatory RNA Nat Rev Genet 15 423-469
  • [6] Strasser-Weippl K(2014)MicroRNAs in cancer: biomarkers, functions and therapy Trends Mol Med 20 460-227
  • [7] Li JJ(2009)MicroRNAs in cancer Annu Rev Pathol 4 199-17
  • [8] St Louis J(2016)Non-coding RNAs: classification, biology and functioning Adv Exp Med Biol 937 3-159
  • [9] Finkelstein DM(2012)MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics A comprehensive review EMBO Mol Med 4 143-1143
  • [10] Yu KD(2015)MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer Theranostics 5 1122-689
12345678910